Takeda Pharmaceutical Co. Ltd. - Debt To Capital Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Debt-To-Capital-Ratio" stands at 39.45 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Debt To Capital Ratio" stands at 39.45 Percent. This represents a decrease of -0.18 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.74 percentage points compared to the value the year prior.
The 1 year change in percentage points is -2.74.
The 3 year change in percentage points is -1.92.

The Serie's long term average value is 40.85 percent. It's latest available value, on 09/30/2025, is 1.40 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0.
The Serie's change in percentage points from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -4.19.